Isto Biologics (Formerly Arteriocyte) Revenue and Competitors
Estimated Revenue & Valuation
- Isto Biologics (Formerly Arteriocyte)'s estimated annual revenue is currently $38.7M per year.
- Isto Biologics (Formerly Arteriocyte)'s estimated revenue per employee is $251,000
Employee Data
- Isto Biologics (Formerly Arteriocyte) has 154 Employees.
- Isto Biologics (Formerly Arteriocyte) grew their employee count by 8% last year.
Isto Biologics (Formerly Arteriocyte)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Operations | Reveal Email/Phone |
3 | VP, Regulatory & Quality Affairs | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | General Counsel | Reveal Email/Phone |
6 | VP Sales and Marketing | Reveal Email/Phone |
7 | VP, Human Resources | Reveal Email/Phone |
8 | Area VP Sales, East | Reveal Email/Phone |
9 | Area VP Sales | Reveal Email/Phone |
10 | Chief Technology Officer | Reveal Email/Phone |
Isto Biologics (Formerly Arteriocyte) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.8M | 39 | 3% | N/A | N/A |
#2 | $8.5M | 34 | 3% | N/A | N/A |
#3 | $3M | 12 | -29% | N/A | N/A |
#4 | $5630M | 7477 | -11% | $450M | N/A |
#5 | $4.5M | 18 | 6% | N/A | N/A |
#6 | $7.2M | 57 | 27% | $29.6M | N/A |
#7 | $14.3M | 57 | -12% | N/A | N/A |
#8 | $2.3M | 18 | 6% | $44M | N/A |
#9 | $40.7M | 162 | -1% | N/A | N/A |
#10 | $45.7M | 182 | -5% | N/A | N/A |
What Is Isto Biologics (Formerly Arteriocyte)?
Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company's best-in-class product offerings include Arteriocyte's market-leading Magellan® Autologous Platelet Separator and Isto's bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; Influx®, a natural bone-graft material; and CellPoint®, a concentrated bone marrow aspirate system.
keywords:N/A
N/A
Total Funding
154
Number of Employees
$38.7M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Hopkinton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 157 | 33% | N/A |
#2 | $54.5M | 171 | 6% | N/A |
#3 | $28.2M | 182 | 0% | N/A |
#4 | N/A | 184 | 40% | N/A |
#5 | $58.5M | 312 | 4% | N/A |